association with, filings with any Regulatory Authority, data, including pharmacological, toxicological, pre-clinical and clinical data, analytical and quality control data, manufacturing data and descriptions, patent and legal data, market data, financial data or descriptions, devices, assays, chemical formulations, specifications, material, compositions of matter, product samples and other samples, physical, chemical and biological materials and compounds, and the like, in written, electronic or other form, now known or hereafter developed, whether or not patentable, including all information concerning any Product and any other technical or business information of whatever nature.
1.5 “Disclosing Party” has the meaning given such term in Section 3.2 of this Agreement.
1.6 “EMA” means the European Medicines Agency or any successor agency thereto.
1.7 “FDA” means the U.S. Food and Drug Administration, or any successor agency thereto.
1.8 “General Scientific Knowledge” means any methods, processes or scientific knowledge used or developed by or for Arena for performance of discovery, research and development activities generally, and any documentation, records, raw materials (other than Materials), specimens, Know-How, or writings related to such methods, processes or scientific knowledge, but excluding (a) any methods or processes disclosed or provided to Arena by or on behalf of Longboard as specified in writing and agreed to by Arena or (b) any methods, processes or scientific knowledge identified or developed in the course of performing the Services that are applicable only to Products.
1.9 “Governmental Authority” means any court, agency, department, authority or other instrumentality of any foreign, federal, state, county, city or other political subdivision.
1.10 “Intellectual Property” means Know-How, Patents, any other indicia of ownership of an invention, trademarks, service marks, trade names, trade dress, domain names, copyrights, trade secrets, inventions, technology, discoveries, software, formulae, processes, confidential and proprietary information and any other similar proprietary rights and registrations and applications for registration for any of the foregoing recognized by any Governmental Authority.
1.11 “Know-How” means technical information and know-how, including biological, chemical, pharmacological, toxicological, clinical, assay and related know-how and trade secrets, and manufacturing data, pre-clinical and clinical data, the specifications of ingredients, the manufacturing processes, formulation, specifications, sourcing information, quality control and testing procedures and related know-how and trade secrets.
1.12 “License Agreement” has the meaning given to such term in the preamble to this Agreement.
1.13 “Longboard Property” has the meaning given such term in Section 4.1 of this Agreement.
2.